Adhera Therapeutics, Inc. announced the appointment of Trond K. Waerness as Chairman of the Company's Board of Directors. Mr. Waerness has been serving as a Director at Adhera since April 2021. Mr. Waerness is assuming the role of Chairman, replacing Andrew Kucharchuk, who will remain Chief Executive Officer and Vice-Chairman.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 USD | -32.58% | -10.45% | -80.00% |
1st Jan change | Capi. | |
---|---|---|
-80.00% | 69.76K | |
-1.56% | 104B | |
+6.57% | 97.47B | |
+5.71% | 22.25B | |
-12.88% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.82% | 16.36B | |
+8.28% | 14.39B | |
+36.50% | 12.37B |
- Stock Market
- Equities
- ATRX Stock
- News Adhera Therapeutics, Inc.
- Adhera Therapeutics, Inc. Appoints Trond K. Waerness as Chairman of the Board